AI-powered screening is clearing regulatory and clinical milestones faster than at any point in women’s health history. FDA-cleared portable breast ultrasound that needs no sonographer. AI mammography proven across 579,000 women to increase cancer detection by 21.6%. The first AI platform ever authorized to predict breast cancer risk five years out. And $2 billion in venture capital now flowing into the space. But 75% of health systems have adopted AI while only 18% have the governance to manage it — and up to 30% of women never follow up after a high-risk mammogram. This panel interrogates whether earlier and faster screening is actually translating to fairer outcomes.